Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypercholesterolemia: HELP
Evan A. Stein
Based on 20 articles published since 2008
||||
Expertise Level
The expertise of Evan A. Stein ranks in the
  • Top 0.025%
  • ... of 27,988 published authors worldwide on Hypercholesterolemia
  • ... from 2008 through 2018
  • ... based on contributions to 20 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Stein, Evan A   ·   Stein, Evan
Work Locations
Details
Most likely:    Miscellaneous institutions in Cincinnati      
2016
  • Metabolic and Atherosclerosis Research Center, Cincinnati, OH, USA. · Pubmed 27669716
  • Metabolic & Atherosclerosis Research Center, Cincinnati, OH. · Louisville Metabolic & Atherosclerotic Research Center, Louisville, KY. · Jacksonville Center for Clinical Research, Jacksonville, FL. · Gemphire Therapeutics Inc., Northville, MI. · Gemphire Therapeutics Inc., Northville, MI. Electronic address: · Pubmed 27678439
  • Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio. · Department of Clinical Development, and Biostatistics, Amgen Inc., Thousand Oaks, California. · The Cardiometabolic Disorders Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, Netherlands. · Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom. · Clinical Trial Service Unit and Epidemiological Services Unit, University of Oxford, Oxford, United Kingdom. · Department of Medicine, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medicine, Baylor College of Medicine and Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Texas. · Department of Pharmacological Sciences, University of Milan, and IRCCS Multimedica, Milan, Italy. · Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany. · Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio. · Department of Cardiology, Hartford Hospital, Hartford, Connecticut. · Pubmed 26946077
  • Cleveland Clinic, Cleveland, Ohio. · University of Amsterdam Faculty of Medicine, Amsterdam, the Netherlands. · Amgen Inc, Thousand Oaks, California. · School of Medicine at Mount Sinai, New York, New York. · Flinders University, Bedford Park, SA, Australia. · University of Glasgow, Glasgow, United Kingdom. · Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom8Epidemiological Services Unit, University of Oxford, Oxford, United Kingdom. · University Hospital of Paris 6, Paris, France. · Charles University in Prague, Prague, Czech Republic11General University Hospital in Prague, Prague, Czech Republic. · David Geffen School of Medicine at the University of California, Los Angeles. · Baylor College of Medicine, Houston, Texas. · Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany. · Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio. · Pubmed 27039291
2015
  • Metabolic & Atherosclerosis Research Center, Cincinnati, Ohio. · Metabolic & Atherosclerosis Research Center, Cincinnati, Ohio. Electronic address: · Pubmed 26548322
2011
  • Metabolic and Atherosclerosis Research Center, Cincinnati, OH 45212, USA. · Pubmed 21518985
2009
  • Metabolic and Atherosclerosis Research Center, 4685 Forest Avenue, Cincinnati, OH, USA. · Pubmed 19217514
2012
Probable:    University of Cincinnati   Contact    
2014
  • Department of Pathology & Laboratory Medicine, University of Cincinnati, Cincinnati, Ohio 45215; email: · Pubmed 24422577
Probable:    Medpace Reference Laboratories      
2013
  • Metabolic & Atherosclerosis Research Center and Medpace Reference Laboratories, 5355 Medpace Way, Cincinnati, OH, USA. · Pubmed 23371064
2012
  • Medpace Reference Laboratories, Inc, 4620 Wesley Avenue, Cincinnati, OH 45212, USA. · Pubmed 22304793
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 20 total) written by Evan A. Stein about Hypercholesterolemia:

  • PCSK9: the Critical Role of Familial Hypercholesterolemia from Discovery to Benefit for all : Editorial to: "Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/Dl or Higher" by Henry N. Ginsberg et Al. 2016
  • Efficacy and safety of gemcabene as add-on to stable statin therapy in hypercholesterolemic patients. 2016
  • Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial. 2016
  • Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial. 2016
  • Non-statin Treatments for Managing LDL Cholesterol and Their Outcomes. 2015
  • Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. 2015
  • PCSK9 Inhibitors and Cardiovascular Events. 2015
  • Reduction of low-density lipoprotein cholesterol by monoclonal antibody inhibition of PCSK9. 2014
  • Potential of proprotein convertase subtilisin/kexin type 9 based therapeutics. 2013
  • Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial. 2012
Show List of Full Article Records
Google Searches

Learn more about Evan A. Stein using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in Cincinnati
University of Cincinnati
Medpace Reference Laboratories
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in Cincinnati
2016
  • Metabolic and Atherosclerosis Research Center, Cincinnati, OH, USA. · Pubmed 27669716
  • Metabolic & Atherosclerosis Research Center, Cincinnati, OH. · Louisville Metabolic & Atherosclerotic Research Center, Louisville, KY. · Jacksonville Center for Clinical Research, Jacksonville, FL. · Gemphire Therapeutics Inc., Northville, MI. · Gemphire Therapeutics Inc., Northville, MI. Electronic address: · Pubmed 27678439
  • Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio. · Department of Clinical Development, and Biostatistics, Amgen Inc., Thousand Oaks, California. · The Cardiometabolic Disorders Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, Netherlands. · Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom. · Clinical Trial Service Unit and Epidemiological Services Unit, University of Oxford, Oxford, United Kingdom. · Department of Medicine, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medicine, Baylor College of Medicine and Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Texas. · Department of Pharmacological Sciences, University of Milan, and IRCCS Multimedica, Milan, Italy. · Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany. · Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio. · Department of Cardiology, Hartford Hospital, Hartford, Connecticut. · Pubmed 26946077
  • Cleveland Clinic, Cleveland, Ohio. · University of Amsterdam Faculty of Medicine, Amsterdam, the Netherlands. · Amgen Inc, Thousand Oaks, California. · School of Medicine at Mount Sinai, New York, New York. · Flinders University, Bedford Park, SA, Australia. · University of Glasgow, Glasgow, United Kingdom. · Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom8Epidemiological Services Unit, University of Oxford, Oxford, United Kingdom. · University Hospital of Paris 6, Paris, France. · Charles University in Prague, Prague, Czech Republic11General University Hospital in Prague, Prague, Czech Republic. · David Geffen School of Medicine at the University of California, Los Angeles. · Baylor College of Medicine, Houston, Texas. · Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany. · Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio. · Pubmed 27039291
2015
  • Metabolic & Atherosclerosis Research Center, Cincinnati, Ohio. · Metabolic & Atherosclerosis Research Center, Cincinnati, Ohio. Electronic address: · Pubmed 26548322
2011
  • Metabolic and Atherosclerosis Research Center, Cincinnati, OH 45212, USA. · Pubmed 21518985
2009
  • Metabolic and Atherosclerosis Research Center, 4685 Forest Avenue, Cincinnati, OH, USA. · Pubmed 19217514
2012
University of Cincinnati
2014
  • Department of Pathology & Laboratory Medicine, University of Cincinnati, Cincinnati, Ohio 45215; email: · Pubmed 24422577
Medpace Reference Laboratories
2013
  • Metabolic & Atherosclerosis Research Center and Medpace Reference Laboratories, 5355 Medpace Way, Cincinnati, OH, USA. · Pubmed 23371064
2012
  • Medpace Reference Laboratories, Inc, 4620 Wesley Avenue, Cincinnati, OH 45212, USA. · Pubmed 22304793
Miscellaneous cities in Ohio
2012
  • Metabolic and Atherosclerosis Research Center, 4685 Forest Ave., Cincinnati, OH 45212, USA. · Pubmed 22435370
12 Other Locations Show
Yearly article counts 00431162210
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.